These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12447733

  • 21. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
    Lancet; 1998 Dec 12; 352(9144):1877-81. PubMed ID: 9863784
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.
    Hirji Z, O'Grady S, Bonham J, Mak M, Takata-Shewchuk J, Hawkins K, Gardam M, Law L, Mazzulli T, Conly J.
    Can Commun Dis Rep; 2001 Feb 01; 27(3):21-4. PubMed ID: 11227819
    [No Abstract] [Full Text] [Related]

  • 27. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.
    Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutkowski R, Ward P, Carr J.
    J Infect Dis; 2004 Feb 01; 189(3):440-9. PubMed ID: 14745701
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Zanamivir: new preparation. No tangible progress against influenza.
    Prescrire Int; 2000 Feb 01; 9(45):199-202. PubMed ID: 11503795
    [Abstract] [Full Text] [Related]

  • 31. Zanamivir. No noticeable progress against influenza.
    Can Fam Physician; 2000 Oct 01; 46():2003-8, 2012-8. PubMed ID: 11184246
    [Abstract] [Full Text] [Related]

  • 32. Zanamivir for influenza virus infections.
    Adelman A.
    J Fam Pract; 1998 Jan 01; 46(1):17-8. PubMed ID: 9451361
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. What is the best antiviral agent for influenza infection?
    Fagan HB, Moeller AH.
    Am Fam Physician; 2004 Oct 01; 70(7):1331-2. PubMed ID: 15508545
    [No Abstract] [Full Text] [Related]

  • 36. Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment.
    Fritz RS, Hayden FG, Calfee DP, Cass LM, Peng AW, Alvord WG, Strober W, Straus SE.
    J Infect Dis; 1999 Sep 01; 180(3):586-93. PubMed ID: 10438343
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
    Hurt AC, Barr IG, Hartel G, Hampson AW.
    Antiviral Res; 2004 Apr 01; 62(1):37-45. PubMed ID: 15026200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.